BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23924858)

  • 1. Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity.
    Zhu X; Dai Y; Chen Z; Xie J; Zeng W; Lin Y
    Oncol Res; 2013; 20(8):377-81. PubMed ID: 23924858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.
    Zhang QL; Tian DA; Xu XJ
    Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway.
    Lin CC; Zhou JP; Liu YP; Liu JJ; Yang XN; Jazag A; Zhang ZP; Guleng B; Ren JL
    PLoS One; 2012; 7(12):e51916. PubMed ID: 23300578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity.
    Zhu XS; Dai YC; Chen ZX; Xie JP; Zeng W; Lin YY; Tan QH
    Crit Rev Eukaryot Gene Expr; 2013; 23(3):275-82. PubMed ID: 23879543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.
    Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
    Hepatol Int; 2016 May; 10(3):493-500. PubMed ID: 26797719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma.
    Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F
    Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells.
    Zhang YQ; Xiao CX; Lin BY; Shi Y; Liu YP; Liu JJ; Guleng B; Ren JL
    PLoS One; 2013; 8(7):e68981. PubMed ID: 23874836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
    Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O
    J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
    Zhang D; Liu J; Wang Y; Chen J; Chen T
    J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma.
    Li WF; Ou Q; Dai H; Liu CA
    Int J Mol Sci; 2015 Aug; 16(8):19419-32. PubMed ID: 26287185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DJ-1 knockdown inhibits growth and xenograft‑induced tumor generation of human hepatocellular carcinoma cells.
    Liu S; Long G; Wei H; Shi L; Yang Z; Liu D; Hu G; Qiu H
    Oncol Rep; 2015 Jan; 33(1):201-6. PubMed ID: 25384406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
    Jin XL; Sun QS; Liu F; Yang HW; Liu M; Liu HX; Xu W; Jiang YY
    J Cell Biochem; 2013 Jul; 114(7):1625-33. PubMed ID: 23355454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pokemon reduces Bcl-2 expression through NF-κ Bp65: A possible mechanism of hepatocellular carcinoma.
    Zhao X; Ning Q; Sun X; Tian D
    Asian Pac J Trop Med; 2011 Jun; 4(6):492-7. PubMed ID: 21771706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
    Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
    Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.